KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Change in Receivables (2020 - 2026)

Esperion Therapeutics filings provide 6 years of Change in Receivables readings, the most recent being $21.2 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 72.19% to $21.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.0 million, a 89.74% increase, with the full-year FY2025 number at $60.0 million, up 89.74% from a year prior.
  • Change in Receivables hit $21.2 million in Q4 2025 for Esperion Therapeutics, up from $11.2 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $26.5 million in Q2 2025 to a low of -$144000.0 in Q3 2021.
  • Median Change in Receivables over the past 5 years was $4.5 million (2021), compared with a mean of $6.4 million.
  • Biggest five-year swings in Change in Receivables: tumbled 105.01% in 2021 and later skyrocketed 2631.25% in 2022.
  • Esperion Therapeutics' Change in Receivables stood at $1.2 million in 2021, then skyrocketed by 83.01% to $2.2 million in 2022, then surged by 162.1% to $5.9 million in 2023, then surged by 109.81% to $12.3 million in 2024, then soared by 72.19% to $21.2 million in 2025.
  • The last three reported values for Change in Receivables were $21.2 million (Q4 2025), $11.2 million (Q3 2025), and $26.5 million (Q2 2025) per Business Quant data.